NPI: 1063665586 · NEWARK, NJ 07107 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/28/2008
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 10/28/2008 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,011 | $889K |
| 2019 | 13,717 | $1.20M |
| 2020 | 8,276 | $401K |
| 2021 | 8,765 | $395K |
| 2022 | 16,762 | $385K |
| 2023 | 2,865 | $148K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,885 | 1,966 | $2.22M |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,463 | 853 | $409K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,659 | 704 | $392K |
| J1756 | Injection, iron sucrose, 1 mg | 3,507 | 748 | $79K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 872 | 256 | $76K |
| A4657 | Syringe, with or without needle, each | 4,961 | 1,246 | $72K |
| 83970 | 615 | 519 | $38K | |
| 85048 | 699 | 593 | $34K | |
| 85041 | 688 | 582 | $34K | |
| 82728 | 286 | 241 | $16K | |
| 83550 | 229 | 199 | $13K | |
| 83540 | 272 | 213 | $13K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 25 | 12 | $13K |
| 82108 | 46 | 36 | $3K | |
| G0008 | Administration of influenza virus vaccine | 53 | 48 | $1.24 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 87 | 46 | $0.00 |
| 90674 | 16 | 13 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 33 | 15 | $0.00 |